Indeed, in several cancers, FOXO6 is elevated and has oncogenic roles, triggering increased proliferation and progression (Qinyu et al., 2013; Rothenberg et al., 2015; Wang et al., 2017; Lallemand et al., 2018). This evidence concerns the gene FOXO6 and cancer.